4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001231919-26-000122
Options or other derivatives
- Director acquired 27,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
RA CAPITAL MANAGEMENT, L.P. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-05 | Grant or award : show line 1 in the form Stock Option (right to buy) | +27,400 | 27,400 | I |
Loading xslF345X05/form4-02092026_100237.xml…